Answers are grounded in this paper and cite their sources.
models. This review aims to describe the role of the FGF19/FGFR4 pathway in hepatocellular carcinoma and its role as a potential predictive biomarker for novel targeted agents against FGF19/FGFR4 signalling.
No takes yet. Share an insight, caveat, or question.
Repana et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: